01 1Dipharma SA
01 1SAPROPTERIN DIHYDROCHLORIDE (NEW PROCESS)
01 1Switzerland
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2020-08-26
Pay. Date : 2020-06-15
DMF Number : 34926
Submission : 2020-06-17
Status : Active
Type : II
20
Dipharma Sa, based in Switzerland, is a pharmaceutical company.
One of their notable products is SAPROPTERIN DIHYDROCHLORIDE (NEW PROCESS), with a corresponding US DMF Number 34926.
Remarkably, this DMF maintains an Active status since its submission on June 17, 2020, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 26, 2020, and payment made on June 15, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II
